These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8810657)

  • 1. Digital infarction in a patient with Raynaud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor. A case report.
    Bell C; Coupland N; Creamer P
    Angiology; 1996 Sep; 47(9):901-3. PubMed ID: 8810657
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.
    Kindler S; Dannon PN; Iancu I; Sasson Y; Zohar J
    Clin Neuropharmacol; 1997 Apr; 20(2):126-9. PubMed ID: 9099464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram-induced Raynaud's phenomenon.
    Peiró AM; Margarit C; Torra M
    Rheumatol Int; 2007 Apr; 27(6):599-601. PubMed ID: 17103176
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female sexual stimulation during antidepressant treatment.
    Elmore JL; Quattlebaum JT
    Pharmacotherapy; 1997; 17(3):612-6. PubMed ID: 9165567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome and fluvoxamine: a case study.
    Bastani JB; Troester MM; Bastani AJ
    Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine and mandibular dystonia.
    Chong SA
    Can J Psychiatry; 1995 Sep; 40(7):430-1. PubMed ID: 8548729
    [No Abstract]   [Full Text] [Related]  

  • 8. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.
    Richard IH; Maughn A; Kurlan R
    Mov Disord; 1999 Jan; 14(1):155-7. PubMed ID: 9918360
    [No Abstract]   [Full Text] [Related]  

  • 9. Complex movement disorder associated with fluvoxamine.
    Bronner IM; Vanneste JA
    Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidality and the use of serotonin reuptake inhibitors.
    Arya DK
    Aust N Z J Psychiatry; 1995 Sep; 29(3):517-8. PubMed ID: 8573060
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity with selective serotonin reuptake inhibitors.
    Solomons K; Gooch S; Wong A
    Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of amyotrophic lateral sclerosis with SIADH and throbbing headache induced by selective serotonin reuptake inhibitor].
    Nakazato Y; Takei K; Yamazato M; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2002 Jan; 42(1):48-50. PubMed ID: 12355854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
    Won M; Minabe Y; Sekine Y; Takei N; Kondo N; Mori N
    J Psychiatry Neurosci; 2003 Mar; 28(2):134-5. PubMed ID: 12670131
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent achievements in the management of Raynaud's phenomenon.
    Baumhäkel M; Böhm M
    Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 18. Case of rapid bilateral cataract development in teenager using selective serotonin reuptake inhibitors.
    Kisilevsky E; Margolin EA
    Can J Ophthalmol; 2014 Oct; 49(5):e114-5. PubMed ID: 25284112
    [No Abstract]   [Full Text] [Related]  

  • 19. SSRIs in children and suicide.
    Klein DF
    Science; 2004 Sep; 305(5689):1401. PubMed ID: 15353779
    [No Abstract]   [Full Text] [Related]  

  • 20. Restlessness related to SSRI withdrawal.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.